Cellares Raises $82M To Solve The Biggest Hurdles In Cell Therapy Manufacturing
Decheng Capital and Eclipse Ventures lead Series B round, bringing total funding to over $100 million Cellares Corporation, a life sciences technology company that automates cell therapy manufacturing, today announced it has secured $82 million in a Series B round, bringing total funding to date to $100 million. The round was led by new investor […]
